| Literature DB >> 32408709 |
Yuri Battaglia1, Ines Ullo2, Sara Massarenti3, Pasquale Esposito4, Michele Prencipe5, Giovanni Ciancio6, Michele Provenzano7, Fulvio Fiorini8, Michele Andreucci7, Alda Storari1, Alice Sabatino9, Enrico Fiaccadori9, Antonio Granata10.
Abstract
Protein Energy Wasting (PEW) in hemodialysis (HD) patients is a multifactorial condition due to specific pathology-related pathogenetic mechanisms, leading to loss of skeletal muscle mass in HD patients. Computed Tomography and Magnetic Resonance Imaging still represent the gold standard techniques for body composition assessment. However, their widespread application in clinical practice is difficult and body composition evaluation in HD patients is mainly based on conventional anthropometric nutritional indexes and bioelectrical impedance vector analysis (BIVA). Little data is currently available on ultrasound (US)-based measurements of muscle mass and fat tissue in this clinical setting. The purpose of our study is to ascertain: (1) if there are differences between quadriceps rectus femoris muscle (QRFM) thickness and abdominal/thigh subcutaneous fat tissue (SFT) measured by US between HD patients and healthy subjects; (2) if there is any correlation between QRFM and abdominal/thigh SFT thickness by US, and BIVA/conventional nutritional indexes in HD patients. We enrolled 65 consecutive HD patients and 33 healthy subjects. Demographic and laboratory were collected. The malnutrition inflammation score (MIS) was calculated. Using B-mode US system, the QRFM and SFT thicknesses were measured at the level of three landmarks in both thighs (superior anterior iliac spine, upper pole of the patella, the midpoint of the tract included between the previous points). SFT was also measured at the level of the periumbilical point. The mono frequency (50 KHz) BIVA was conducted using bioelectrical measurements (Rz, resistance; Xc, reactance; adjusted for height, Rz/H and Xc/H; PA, phase angle). 58.5% were men and the mean age was 69 (SD 13.7) years. QRFM and thigh SFT thicknesses were reduced in HD patients as compared to healthy subjects (p < 0.01). Similarly, also BIVA parameters, expression of lean body mass, were lower (p < 0.001), except for Rz and Rz/H in HD patients. The average QRFM thickness of both thighs at top, mid, lower landmarks were positively correlated with PA and body cell mass (BCM) by BIVA, while negatively correlated with Rz/H (p < 0.05). Abdominal SFT was positively correlated with PA, BCM and basal metabolic rate (BMR) (p < 0.05). Our study shows that ultrasound QRFM and thigh SFT thicknesses were reduced in HD patients and that muscle ultrasound measurements were significantly correlated with BIVA parameters.Entities:
Keywords: BIVA; PEW; fat tissue; muscle mass; ultrasonography
Mesh:
Year: 2020 PMID: 32408709 PMCID: PMC7285004 DOI: 10.3390/nu12051388
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Demographic, and clinical data of hemodialysis patients.
| Socio-Demographic Variables | Clinical Variables | ||
|---|---|---|---|
| Age, years * | 69 (13.7) | Systolic Blood Pressure, mm hg * | 138.3 (22.8) |
| Sex, Males, | 38 (58.5) | Diastolic Blood Pressure, mm hg * | 73.4 (11.8) |
| Weight loss, last 6 months ** | −1.0 (−2.5–0.45) | Heart Rate, bpm * | 68.4 (9.4) |
| Height, cm * | 165.7 (10.4) | ||
| Diabetes mellitus, % | 29.2 | Weight, kg * | 68 (16.9) |
| Caucasian race, % | 98.5 | Body Mass Index, kg/m2 * | 24.6 (4.9) |
| Diabetes mellitus, % | 29.2 | ||
| Previous Stroke, % | 20 | Blood Test Values | |
| COPD, % | 18.5 | Serum phosphorus, mg/dL * | 6.1 (2.5) |
| Cardiovascular diseases, % | 36.9 | Serum calcium, mg/dL * | 9.3 (0.8) |
| PAD, % | 30.8 | PTH, pg/mL ** | 217 (116.5–377) |
| Previous renal transplantation, % | 9.2 | Albumin, g/dL * | 3.7 (0.4) |
| History of cancer, % | 30.8 | Ferritin, microg/L ** | 285 (80.5–491.5) |
| Transferrin, mg/dL * | 188.4 (43.5) | ||
| Kidney disease: | Serum iron, microg/dL * | 57.8 (29.3) | |
| Glomerulonephritis, % | 20 | Total Iron Binding Capacity, mg/dL * | 235.5 (54.3) |
| Nephroangiosclerosis, % | 16.9 | Total Cholesterol, mg/dL * | 161.3 (47.4) |
| ADPKD, % | 4.6 | HDL Cholesterol, mg/dL * | 39.9 (11.2) |
| Others, % | 26.2 | Triglycerides, mg/dL ** | 140 (103–197) |
| C-reactive Protein, mg/dL ** | 0.46 (0.19–0.85) | ||
| KT/V | 1.4 (0.3) | ||
* Data are expressed as means (standard deviations); ** Data are expressed as median and range Interquartile; ADPKD: Autosomal dominant polycystic kidney disease; COPD: chronic obstructive pulmonary disease; HDL: high-density lipoprotein; PAD: peripheral artery disease; PTH: parathormone.
Figure 1Quadriceps rectus femoris thickness of hemodialysis patients and healthy subjects; ∞ significance = p < 0.01; QRFT: Quadriceps rectus femoris thickness; LT: left thigh; RT: right thigh.
Figure 2Abdominal/thigh subcutaneous fat thickness of hemodialysis patients and heathy subjects; ∞ significance = p < 0.01; SFT: subcutaneous fat tissue; LT: left thigh; RT: right thigh.
Correlation between SFT / QRTM thickness and nutritional indexes (BMI, albumin, MIS score) in hemodialysis patients.
| Dependent Variable: BMI | |||||||
|---|---|---|---|---|---|---|---|
| Model | UC | SC |
| Sig. | 95 % CI | ||
| B | St. Error | Beta | LB | UB | |||
| (Constant) | 13.369 | 2.448 | 5.461 | 0.000 | 8.470 | 18.267 | |
| Abdominal SFT thickness | 1.341 | 0.507 | 0.323 | 2.646 | 0.010 | 0.327 | 2.356 |
| Lower QRFM thickness | 10.173 | 3.067 | 0.350 | 3.317 | 0.002 | 4.036 | 16.310 |
|
| |||||||
|
|
|
|
|
|
| ||
|
|
|
|
|
| |||
| (Constant) | 18.141 | 2.713 | 6.688 | 0.000 | 12.713 | 23.569 | |
| Mid Thigh SFT thickness | 3.381 | 1.841 | 0.343 | 1.837 | 0.071 | −0.303 | 7.064 |
| Lower Thigh SFT thickness | −3.584 | 2.004 | −0.339 | −1.788 | 0.079 | −7.594 | 0.427 |
| Top QRFM thickness | −4.432 | 1.320 | −0.377 | −3.358 | 0.001 | −7.073 | −1.791 |
| Lower QRFM thickness | −6.007 | 3.221 | −0.208 | −1.865 | 0.067 | −12.453 | 0.439 |
|
| |||||||
|
|
|
|
|
|
| ||
|
|
|
|
|
| |||
| (Constant) | 3.480 | 0.224 | 15.506 | 0.000 | 3.031 | 3.929 | |
| Mid Thigh SFT thickness | −0.489 | 0.152 | −0.622 | −3.211 | 0.002 | −0.794 | −0.184 |
| Top QRFM thickness | 0.195 | 0.109 | 0.208 | 1.789 | 0.079 | −0.023 | 0.414 |
BMI: Body Mass Index; CI: Confidence Interval; LB: Lower Bound; LT: Left Thigh; MIS: Malnutrition Inflammation Score; PA: Phase Angles; QRFM: Quadriceps Rectus Femoris Muscle; RT: Right Thigh; SC: Standardized Coefficients; SFT: Subcutaneous Fat Tissue; UB: Upper Bound; UC: Unstandardized Coefficients.
Bioelectrical impedance analysis parameters of hemodialysis patients and heathy subjects.
| Patients ( | Controls ( |
| |
|---|---|---|---|
| Rz | 545.7 (82.9) | 569.5 (69.6) | 0.63 |
| Xc | 42.8 (11.3) | 60.3 (9.3) | 0.001 |
| Rz/H | 3.3 (0.58) | 3.5 (0.5) | 0.46 |
| Xc/H | 0.26 (0.07) | 0.4 (0.07) | 0.003 |
| BCM | 19.8 (8.3) | 24.4 (5.9) | <0.001 |
| BMR KJOULE | 5362.9 (1262.9) | 6203.5 (522.7) | 0.007 |
| BMR KCAL | 1262.5 (340.1) | 1482.7 (124.9) | <0.01 |
| ECW | 29.2 (15.9) | 15.3 (3.3) | 0.005 |
| PHASE ANGLE | 4.5 (1.2) | 6.1 (0.8) | <0.001 |
Data are expressed as means (standard deviations); BCM: Body cell mass; BMR: basic metabolic rate; ECW: extra-cellular mass; H: height; Rz: resistance; Xc: reactance.
Correlation between quadriceps rectus femoris thickness and BIVA parameters in hemodialysis patients.
| RZ | RZ/H | XC | XC/H | BCM | BMR KJOULE | PHASE ANGLE | |
|---|---|---|---|---|---|---|---|
|
| −0.236(0.058) | −0.319 (0.010) * | 0.125 (0.322) | 0.055 (0.661) | 0.12 (0.011) * | 0.355 (0.004) * | 0.315 (0.011) * |
|
| −0.257 (0.039) * | −0.264(0.034) * | 0.11 (0.383) | 0.093 (0.461) | 0.258 (0.038) * | 0.294 (0.018) * | 0.232 (0.043) * |
|
| −0.239 (0.057) | −0.273 (0.029) * | −0.280 (0.025) | 0.212 (0.092) | 0.365 (0.003) * | 0.128 (0.312) | 0.423 (<0.001) * |
* significance = p < 0.05; BCM: Body cell mass; BMR: basic metabolic rate; H: height; QRFM: quadriceps rectus femoris; Rz: resistance; Xc: reactance.
Correlation between abdominal/thigh subcutaneous fat thickness and BIVA parameters in hemodialysis patients.
| Rz | Rz/H | Xc | Xc/H | BCM | BMR KJOULE | PHASE ANGLE | |
|---|---|---|---|---|---|---|---|
| Abdominal SFT thickness ( | −0.148 (0.239) | −0.204 (0.102) | 0.218 (0.081) | 0.161 (0.200) | 0.294 (0.018) * | 0.303 (0.014) * | 0.299 (0.016) * |
| Top Thigh SFT thickness ( | −0.27 (0.83) | 0.036 (0.778) | −0.001 (0.992) | 0.033 (0.793) | 0.013 (0.919) | −0.041 (0.746) | −0.034 (0.785) |
| Mid Thigh SFT thickness ( | 0.014 (0.91) | 0.161 (0.2) | −0.055 (0.661) | 0.043 (0.732) | −0.211 (0.092) | −0.119 (0.346) | −0.087 (0.493) |
| Lower Thigh SFT thickness ( | −0.088 (0.487) | −0.018 (0.886) | 0.068 (0.588) | 0.212 (0.089) | 0.066 (0.601) | 0.160 (0.204) | 0.225 (0.071) |
* significance = p < 0.05; BCM: Body cell mass; BMR: basic metabolic rate; H: height; Rz: resistance; SFT: subcutaneous fat tissue; Xc: reactance.